团队近期发表代表性论文
1. Li, Z., M. Peng, P. Chen, C. Liu, A. Hu, Y.Zhang, J. Peng, J. Liu, Y. Li & W. Li (2022) Imatinib and methazolamideameliorate COVID-19-induced metabolic complications via elevating ACE2enzymatic activity and inhibiting viral entry. Cell Metabolism. (IF 27.287)
2. Liu X, Guo JW, Lin XC, et al. Macrophage NFATc3prevents foam cell formation and atherosclerosis: evidence and mechanisms. EurHeart J. 2021;42(47):4847-4861. (IF 29.983)
3. Lu J, Li P, Ma K, et al. OPG/TRAIL ratio as apredictive biomarker of mortality in patients with type A acute aorticdissection. Nat Commun. 2021;12(1):3401. Published 2021 Jun7. (IF 14.919)
4. Liang J, Zhang X, Xia W, et al. Promotion ofAerobic Exercise Induced Angiogenesis Is Associated With Decline in BloodPressure in Hypertension: Result of EXCAVATION-CHN1. Hypertension.2021;77(4):1141-1153. (IF 10.19)
5. Zhou Z, Xing AJ, Zhang JN, et al. Hypertension,Arterial Stiffness, and Clinical Outcomes: A Cohort Study of ChineseCommunity-Based Population. Hypertension. 2021;78(2):333-341. (IF 10.19)
6. Liu X, Chen A, Liang Q, et al. Spermidineinhibits vascular calcification in chronic kidney disease through modulation ofSIRT1 signaling pathway. Aging Cell. 2021;20(6):e13377. (IF 9.304)
7. Yan Y, Tang R, Li B, et al. The cardiactranslational landscape reveals that micropeptides are new players involved incardiomyocyte hypertrophy. Mol Ther. 2021;29(7):2253-2267. (IF 8.986)
8. He X, Liu J, Gu F, et al. Cardiac CIP proteinregulates dystrophic cardiomyopathy. Mol Ther. 2022;30(2):898-914. (IF 8.986)
9. Liang W, Wu Y, Xue R, et al. C2HEST scorepredicts clinical outcomes in heart failure with preserved ejection fraction: asecondary analysis of the TOPCAT trial. BMC Med. 2021;19(1):44.Published 2021 Feb 18.(IF 8.775)
10. Zhu W, Ye Z, Chen S, et al. Comparative Effectivenessand Safety of Non-Vitamin K Antagonist Oral Anticoagulants in AtrialFibrillation Patients. Stroke. 2021;52(4):1225-1233. (IF 7.914)
11. Yang X, Chen A, Liang Q, et al. Up-regulationof heme oxygenase-1 by celastrol alleviates oxidative stress and vascularcalcification in chronic kidney disease. Free Radic Biol Med.2021;172:530-540. (IF 7.376)
12. Ou LC, Zhong S, Ou JS, Tian JW. Application oftargeted therapy strategies with nanomedicine delivery for atherosclerosis. ActaPharmacol Sin. 2021;42(1):10-17. (IF 6.15)
13. Zhang J, Liang J, Zhang X, et al. Non-invasiveSystemic Hemodynamic Index in Vascular Risk Stratification Tailored forHypertensives. Front Cardiovasc Med. 2021;8:744349. Published 2021Nov 22. (IF 6.05)
14. Liu X, Huang Z, Zhang Y, et al. LacidipineAmeliorates the Endothelial Senescence and Inflammatory Injury ThroughCXCR7/P38/C/EBP-β Signaling Pathway. Front Cardiovasc Med.2021;8:692540. Published 2021 Jul 6. (IF 6.05)
15. Liu W, Cheng L, Chen K, et al. Identificationof Novel Single-Nucleotide Variants With Potential of Mediating Malfunction ofMicroRNA in Congenital Heart Disease. Front Cardiovasc Med.2021;8:739598. Published 2021 Sep 10. (IF 6.05)
16. Yang T, Long T, Du T, Chen Y, Dong Y, Huang ZP.Circle the Cardiac Remodeling With circRNAs. Front Cardiovasc Med.2021;8:702586. Published 2021 Jun 25. (IF 6.05)
17. Li Y, Yu Y, Wu Y, et al. Association ofBody-Weight Fluctuation With Outcomes in Heart Failure With Preserved EjectionFraction. Front Cardiovasc Med. 2021;8:689591. Published 2021 Jun14. (IF 6.05)
18. Huang P, Guo Z, Liang W, et al. Weight Changeand Mortality Risk in Heart Failure With Preserved Ejection Fraction. FrontCardiovasc Med. 2021;8:681726. Published 2021 Jun 4. (IF 6.05)
19. Li Y, Yuan H, Chen C, et al. Concentration ofcirculating microparticles: a new biomarker of acute heart failure aftercardiac surgery with cardiopulmonary bypass. Sci China Life Sci.2021;64(1):107-116. (IF 6.038)
20. Li Y, Zhang YX, Ning DS, et al. Simvastatininhibits POVPC-mediated induction of endothelial-to-mesenchymal celltransition. J Lipid Res. 2021;62:100066. (IF 5.922)
21. Huang K, Liu C, Peng M, et al.Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiotain Apolipoprotein E-Deficient Mice. J Am Heart Assoc. 2021;10(7):e019820. (IF 5.501)
22. Li Y, Wang J, He R, et al. Feasibility ofanticoagulation using low molecular-weight heparin during catheter-directedthrombolysis for lower extremity deep venous thrombosis. Thromb J.2021;19(1):6. Published 2021 Jan 28. (IF 5.5)
23. Zheng L, Wang Z, Li Z, Wang M, Wang W, Chang G.MicroRNA-130a inhibits proliferation of vascular smooth muscle cells bysuppressing autophagy via ATG2B. J Cell Mol Med.2021;25(8):3829-3839. (IF 5.31)
24. Ning DS, Ma J, Peng YM, et al. ApolipoproteinA-I mimetic peptide inhibits atherosclerosis by increasing tetrahydrobiopterinvia regulation of GTP-cyclohydrolase 1 and reducing uncoupled endothelialnitric oxide synthase activity. Atherosclerosis.2021;328:83-91. (IF5.162)
25. Li Z, Yin M, Zhang H, et al. BMX RepressesThrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage DuringEarly Sepsis. Circ Res. 2020;126(4):471-485. (IF 15.862)
26. Yu B, Dong B, He J, et al. BimodalImaging-Visible Nanomedicine Integrating CXCR4 and VEGFa Genes Directs SynergisticReendothelialization of Endothelial Progenitor Cells. Adv Sci (Weinh).2020;7(24):2001657. Published 2020 Nov 9. (IF 15.84)
27. Guo JW, Liu X, Zhang TT, et al. HepatocyteTMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose MetabolicDisorder. Adv Sci (Weinh). 2020;7(10):1903657. Published 2020 Mar20. (IF 15.84)
28. Song Y, Li L, Yang W, et al. Sense-antisensemiRNA pairs constitute an elaborate reciprocal regulatory circuit. GenomeRes. 2020;30(5):661-672. (IF 11.093)
29. Fang EF, Xie C, Schenkel JA, et al. A researchagenda for ageing in China in the 21st century (2nd edition): Focusing on basicand translational research, long-term care, policy and social networks. AgeingRes Rev. 2020;64:101174. (IF 10.616)
30. Li HM, Mo ZW, Peng YM, et al. Angiogenic andAntiangiogenic mechanisms of high density lipoprotein from healthy subjects andcoronary artery diseases patients. Redox Biol. 2020;36:101642. (IF 9.986)
31. Hu Y, Hu Y, Xiao Y, et al. Genetic landscapeand autoimmunity of monocytes in developing Vogt-Koyanagi-Harada disease. ProcNatl Acad Sci U S A. 2020;117(41):25712-25721. (IF 9.412)
32. Xu C, Yang X, Zhou H, et al. A novel ZRSvariant causes preaxial polydactyly type I by increased sonic hedgehogexpression in the developing limb bud. Genet Med.2020;22(1):189-198. (IF 8.904)
33. Li H, Zhang M, Wei Y, et al. SH3BGRL confersinnate drug resistance in breast cancer by stabilizing HER2 activation on cellmembrane. J Exp Clin Cancer Res. 2020;39(1):81. Published 2020 May7. (IF 7.068)
34. Tang R, Long T, Lui KO, Chen Y, Huang ZP. ARoadmap for Fixing the Heart: RNA Regulatory Networks in Cardiac Disease. MolTher Nucleic Acids. 2020;20:673-686. (IF 7.032)
35. Zheng N, Xie K, Ye H, et al. TLR7 in B cellspromotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy. JCIInsight. 2020;5(14):e136965. Published 2020 Jul 23. (6.205)
36. Ye J, Huang A, Wang H, et al. PRDM3 attenuatespancreatitis and pancreatic tumorigenesis by regulating inflammatory response. CellDeath Dis. 2020;11(3):187. Published 2020 Mar 16. (5.959)
37. Wang Z, Qi Y, Wang R, et al. IGFBP6 regulatesvascular smooth muscle cell proliferation and morphology via cyclin E-CDK2. JCell Physiol. 2020;235(12):9538-9556. (IF 5.546)
38. Wang M, Riambau V. Is TEVAR an Optimal Strategyfor Retrograde Type A Intramural Haematoma?. Eur J Vasc Endovasc Surg.2020;60(3):394. (IF 5.328)
39. Deng Y, Zhou Z, Ji W, Lin S, Wang M.METTL1-mediated m7G methylation maintains pluripotency in human stem cells andlimits mesoderm differentiation and vascular development. Stem Cell ResTher. 2020;11(1):306. Published 2020 Jul 22. (IF 5.116)
40. Ou LC, Zhong S, Ou JS, Tian JW. Application oftargeted therapy strategies with nanomedicine delivery for atherosclerosis. ActaPharmacol Sin. 2021;42(1):10-17. (IF 5.064)
41. Yang X, Zhong D, Gao W, et al. Conditionalablation of MAPK7 expression in chondrocytes impairs endochondral boneformation in limbs and adaptation of chondrocytes to hypoxia. Cell Biosci.2020;10:103. Published 2020 Sep 10. (IF 5.026)
42. Lin S, Liu Q, Jiang YZ, Gregory RI. Nucleotideresolution profiling of m7G tRNA modification by TRAC-Seq. NatProtoc. 2019;14(11):3220-3242. (IF 11.334)
43. Sun Y, Chen C, Xue R, et al. Maf1 amelioratescardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2. Theranostics.2019;9(24):7268-7281. Published 2019 Sep 25. (IF 8.063)
44. Sun Y, Fan W, Xue R, et al. TranscribedUltraconserved Regions, Uc.323, Ameliorates Cardiac Hypertrophy by Regulatingthe Transcription of CPT1b (Carnitine Palmitoyl transferase 1b). Hypertension.2020;75(1):79-90. (IF 7.017)
45. He J, Liu X, Su C, et al. Inhibition ofMitochondrial Oxidative Damage Improves Reendothelialization Capacity ofEndothelial Progenitor Cells via SIRT3 (Sirtuin 3)-Enhanced SOD2 (SuperoxideDismutase 2) Deacetylation in Hypertension. Arterioscler Thromb VascBiol. 2019;39(8):1682-1698. (IF 6.618)
46. Yu BB, Zhi H, Zhang XY, et al. Mitochondrialdysfunction-mediated decline in angiogenic capacity of endothelial progenitorcells is associated with capillary rarefaction in patients with hypertensionvia downregulation of CXCR4/JAK2/SIRT5 signaling. EBioMedicine.2019;42:64-75. (IF 6.183)
47. Zhang W, Xia D, Li Z, et al.Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breastcancer and dual-targeting Aurora-A/mTOR shows synthetic lethality. CellDeath Dis. 2019;10(8):606. Published 2019 Aug 13. (IF 5.959)
48. Su Y, Yuan J, Zhang F, et al. MicroRNA-181a-5pand microRNA-181a-3p cooperatively restrict vascular inflammation andatherosclerosis. Cell Death Dis. 2019;10(5):365. Published 2019 May7. (IF 5.959)
49. Wang TT, Shi MM, Liao XL, et al. Overexpressionof inducible nitric oxide synthase in the diabetic heart compromises ischemicpostconditioning. J Mol Cell Cardiol. 2019;129:144-153. (IF 5.055)
50. Hu W, Chang G, Zhang M, et al. MicroRNA-125a-3paffects smooth muscle cell function in vascular stenosis. J Mol CellCardiol. 2019;136:85-94. (IF 5.055)